230 related articles for article (PubMed ID: 35439935)
1. Integrative analysis of mutated genes and mutational processes reveals novel mutational biomarkers in colorectal cancer.
Dashti H; Dehzangi I; Bayati M; Breen J; Beheshti A; Lovell N; Rabiee HR; Alinejad-Rokny H
BMC Bioinformatics; 2022 Apr; 23(1):138. PubMed ID: 35439935
[TBL] [Abstract][Full Text] [Related]
2. Whole-Genome Analysis of De Novo Somatic Point Mutations Reveals Novel Mutational Biomarkers in Pancreatic Cancer.
Ghareyazi A; Mohseni A; Dashti H; Beheshti A; Dehzangi A; Rabiee HR; Alinejad-Rokny H
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503185
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer integrative analysis of whole-genome De novo somatic point mutations reveals 17 cancer types.
Ghareyazi A; Kazemi A; Hamidieh K; Dashti H; Tahaei MS; Rabiee HR; Alinejad-Rokny H; Dehzangi I
BMC Bioinformatics; 2022 Jul; 23(1):298. PubMed ID: 35879674
[TBL] [Abstract][Full Text] [Related]
4. Impact of mini-driver genes in the prognosis and tumor features of colorectal cancer samples: a novel perspective to support current biomarkers.
Campos Segura AV; Velásquez Sotomayor MB; Gutiérrez Román AIF; Ortiz Rojas CA; Murillo Carrasco AG
PeerJ; 2023; 11():e15410. PubMed ID: 37214090
[TBL] [Abstract][Full Text] [Related]
5. Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities.
Wang W; Kandimalla R; Huang H; Zhu L; Li Y; Gao F; Goel A; Wang X
Semin Cancer Biol; 2019 Apr; 55():37-52. PubMed ID: 29775690
[TBL] [Abstract][Full Text] [Related]
6. Actionable Potentials of Less Frequently Mutated Genes in Colorectal Cancer and Their Roles in Precision Medicine.
Mohd Yunos RI; Ab Mutalib NS; Tieng FYF; Abu N; Jamal R
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32245111
[TBL] [Abstract][Full Text] [Related]
7. Major driver mutations are shared between sinonasal intestinal-type adenocarcinoma and the morphologically identical colorectal adenocarcinoma.
Sjöstedt S; Schmidt AY; Vieira FG; Willemoe GL; Agander TK; Olsen C; Nielsen FC; von Buchwald C
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1019-1027. PubMed ID: 33051725
[TBL] [Abstract][Full Text] [Related]
8. Strategies to target energy metabolism in consensus molecular subtype 3 along with Kirsten rat sarcoma viral oncogene homolog mutations for colorectal cancer therapy.
Wang G; Wang JJ; Yin PH; Xu K; Wang YZ; Shi F; Gao J; Fu XL
J Cell Physiol; 2019 May; 234(5):5601-5612. PubMed ID: 30341899
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of 13 driver genes of colorectal cancer-related pathways in Taiwanese patients.
Chang YC; Chang JG; Liu TC; Lin CY; Yang SF; Ho CM; Chen WT; Chang YS
World J Gastroenterol; 2016 Feb; 22(7):2314-25. PubMed ID: 26900293
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic characteristics of FBXW7-mutated colorectal adenocarcinoma and association with aberrant beta-catenin localization.
Escobar D; Bushara O; Sun L; Liao J; Yang GY
Hum Pathol; 2022 Jan; 119():51-58. PubMed ID: 34717891
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive functional genomic analyses link APC somatic mutation and mRNA-miRNA networks to the clinical outcome of stage-III colorectal cancer patients.
Chiang SF; Huang HH; Tsai WS; Chin-Ming Tan B; Yang CY; Huang PJ; Yi-Feng Chang I; Lin J; Lu PS; Chin E; Liu YH; Yu JS; Chiang JM; Hung HY; You JF; Liu H
Biomed J; 2022 Apr; 45(2):347-360. PubMed ID: 35550340
[TBL] [Abstract][Full Text] [Related]
12. Genetic Molecular Subtypes in Optimizing Personalized Therapy for Metastatic Colorectal Cancer.
Włodarczyk M; Włodarczyk J; Siwiński P; Sobolewska-Włodarczyk A; Fichna J
Curr Drug Targets; 2018; 19(15):1731-1737. PubMed ID: 30073926
[TBL] [Abstract][Full Text] [Related]
13. Molecular subtypes in early colorectal cancer associated with clinical features and patient prognosis.
Gil-Raga M; Jantus-Lewintre E; Gallach S; Giner-Bosch V; Frangi-Caregnato A; Safont-Aguilera MJ; Garde-Noguera J; Zorraquino-Pina E; García-Martínez M; Camps-Herrero C
Clin Transl Oncol; 2018 Nov; 20(11):1422-1429. PubMed ID: 29802524
[TBL] [Abstract][Full Text] [Related]
14. Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer.
Yu J; Wu WK; Li X; He J; Li XX; Ng SS; Yu C; Gao Z; Yang J; Li M; Wang Q; Liang Q; Pan Y; Tong JH; To KF; Wong N; Zhang N; Chen J; Lu Y; Lai PB; Chan FK; Li Y; Kung HF; Yang H; Wang J; Sung JJ
Gut; 2015 Apr; 64(4):636-45. PubMed ID: 24951259
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
[TBL] [Abstract][Full Text] [Related]
16. [Molecular phenotypes of colorectal cancer is critical in clinical individual treatment].
Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Oct; 18(10):994-7. PubMed ID: 26499143
[TBL] [Abstract][Full Text] [Related]
17. The impact of somatic SMAD4 mutations in colorectal liver metastases.
Xourafas D; Mizuno T; Cloyd JM
Chin Clin Oncol; 2019 Oct; 8(5):52. PubMed ID: 31500428
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of Genomic and Expression Data Identified Potential Markers for Predicting Prognosis and Immune Response in CRC.
He Y; Dai X; Chen Y; Huang S
Genet Res (Camb); 2022; 2022():1831211. PubMed ID: 35975176
[TBL] [Abstract][Full Text] [Related]
19. Molecular Insights Into Colorectal Carcinoma.
Requena DO; Garcia-Buitrago M
Arch Med Res; 2020 Nov; 51(8):839-844. PubMed ID: 32962865
[TBL] [Abstract][Full Text] [Related]
20. One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status.
Myte R; Gylling B; Häggström J; Schneede J; Löfgren-Burström A; Huyghe JR; Hallmans G; Meyer K; Johansson I; Ueland PM; Palmqvist R; Van Guelpen B
PLoS One; 2018; 13(4):e0196233. PubMed ID: 29694444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
